Dr. Bryce Frederick Sullivan, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 910 N Main St, Edwardsville, IL 62025 Phone: 618-659-8787 |
Rachel V. Tompkins, PH.D. Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 118 S Main St, Edwardsville, IL 62025 Phone: 618-656-0696 Fax: 618-656-9697 |
Carla Michelle Burdette Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 1805 Esic Dr, Edwardsville, IL 62025 Phone: 618-973-6930 |
Jamie L Unger, SSP Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 1317 Gerber Woods Dr, Edwardsville, IL 62025 Phone: 618-698-6178 |
Harry J Deppe, PHD Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 103a Southpointe, Edwardsville, IL 62025 Phone: 618-656-2000 Fax: 618-656-1169 |
Dr. Jeremy Dean Jewell, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 910 N Main St, Edwardsville, IL 62025 Phone: 618-659-8787 |
Alexander R James, PH.D. Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 118 S Main St, Edwardsville, IL 62025 Phone: 618-656-0696 Fax: 618-656-9697 |
News Archive
The Associated Press: "After months spent criticizing Democrats' health overhaul plans, House Republicans have produced a draft proposal of their own. It's much shorter and focuses on bringing down costs rather than extending coverage to nearly all Americans."
A new finding in neuroscience for the first time points to a developmental mechanism linking the disease-causing mutation in an autism-related disorder, Timothy syndrome, and observed defects in brain wiring, according to a study led by scientist Ricardo Dolmetsch and published online yesterday in Nature Neuroscience.
In an Editorial published this week in PLOS Medicine, editors ask an international panel of eleven expert researchers and clinicians spanning a range of specialties to answer questions on their field and what developments they hope and expect to see in 2016.
Alectos Therapeutics Inc. today announced a research collaboration with Merck, headquartered in Whitehouse Station, N.J., to identify and develop compounds that modulate O-linked N-acetylglucosaminidase (O-GlcNAcase) an enzyme that is believed to be involved in the development of Alzheimer's disease and potentially other disorders. The agreement provides Merck with a worldwide, exclusive license to research, develop and commercialize compounds that modulate this target.
Employers are increasingly looking to workplace wellness programs to motivate employees to play an active role in improving their health, thereby reducing overall healthcare costs. Deepak N. Patel, MD, Mmed, senior clinical specialist for Discovery Vitality, will present new findings indicating that health plan members who participated in health and fitness-related activities within an incentive-based health insurance wellness program had significantly lower healthcare costs.
› Verified 8 days ago